BeOne Medicines (49BA) Q2 2025 Earnings Report
DE:49BA Q2 2025 EPS Results
- Actual EPS
- EUR 0.81
- Consensus EPS
- EUR 0.35
- Beat/Miss
- Beat by +EUR 0.47
- One Year Ago EPS
- -EUR 1.03
DE:49BA Q2 2025 Revenue Results
- Actual Revenue
- EUR 1.18B
- Expected Revenue
- EUR 1.11B
- Beat/Miss
- Beat by +EUR 70.87M
- YoY Revenue Growth
- +42.23%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/06/2025
- Time
- Before Open
- Conference Call
- Wednesday, August 6, 2025
DE:49BA Upcoming Earnings
BeOne Medicines's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
DE:49BA Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:49BA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | 1.70- | 0.97 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 1.491.83 | 0.81 | 125.27% (+1.02) | |
| May 06, 2026 | 2026 (Q1) | 0.871.75 | 0 | ― | |
| Feb 26, 2026 | 2025 (Q4) | 1.110.54 | -1.28 | 141.96% (+1.82) | |
| Nov 06, 2025 | 2025 (Q3) | 0.760.97 | -1.03 | 194.78% (+2.00) | |
| Aug 06, 2025 | 2025 (Q2) | 0.350.81 | -1.03 | 179.13% (+1.84) | |
| May 07, 2025 | 2025 (Q1) | -0.510.00 | -2.15 | 100.00% (+2.15) | |
| Feb 27, 2025 | 2024 (Q4) | -0.90-1.28 | -3.16 | 59.49% (+1.88) | |
| Nov 12, 2024 | 2024 (Q3) | -1.00-1.03 | 1.8 | -157.21% (-2.83) | |
| Aug 26, 2024 | 2024 (Q2) | -1.96-1.03 | -3.25 | 68.41% (+2.23) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
